Document is current
Any future updates will be listed below
-
Authors
Shahbazian, Haneyeh
Birnbaum, Jason
Burns, Patricia J.
Shabanan, Sedighe Hosseini
Kanmaniraja, Devaraju
Reinus, John
Kamel, Ihab
Sirlin, Claude B.
Chernyak, Victoria https://orcid.org/0000-0002-5715-1403
- License Information
-
More Information
Article History
Received: 31 July 2023
Revised: 22 August 2023
Accepted: 24 August 2023
First Online: 19 September 2023
Declarations
:
: V. Chernyak: Consultant, Bayer. CB Sirlin: Dr. Sirlin reports research grants from ACR, Bayer, Foundation of NIH, GE, Gilead, Pfizer, Philips, Siemens; lab service agreements with Enanta, Gilead, ICON, Intercept, Nusirt, Shire, Synageva, Takeda; institutional consulting for BMS, Exact Sciences, IBM-Watson, Pfizer; Personal consulting for Altimmune, Ascelia Pharma, Blade, Boehringer, Epigenomics; and Guerbet; receipt of royalties and/or honoraria from Medscape and Wolters Kluwer; ownership of stock options in Livivos; unpaid advisory board position in Quantix Bio. Dr. Sirlin serves as Chief Medical Officer for Livivos (unsalaried position with stock options), an appointment approved by his university.
: Institutional Review Board approval was obtained.
: Written informed consent was waived by the Institutional Review Board.
